These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9794158)

  • 21. Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine.
    Tatsumi Y; Yokoo M; Senda H; Kakehi K
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3797-801. PubMed ID: 12435679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Action mechanisms of modern antifungal agents and resulting problems in the management of onychomycosis.
    Seebacher C
    Mycoses; 2003 Dec; 46(11-12):506-10. PubMed ID: 14641625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcomes in the treatment of toenail onychomycosis.
    De Cuyper C; Hindryckx PH
    Br J Dermatol; 1999 Nov; 141 Suppl 56():15-20. PubMed ID: 10730909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 12-week treatment for dermatophyte toe onychomycosis: terbinafine 250 mg/day vs. itraconazole 200 mg/day--a double-blind comparative trial.
    De Backer M; De Keyser P; De Vroey C; Lesaffre E
    Br J Dermatol; 1996 Jun; 134 Suppl 46():16-7: discussion 38. PubMed ID: 8763462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral terbinafine and itraconazole treatments against dermatophytes appear not to favor the establishment of Fusarium spp. in nail.
    Verrier J; Bontems O; Baudraz-Rosselet F; Monod M
    Dermatology; 2014; 228(3):225-32. PubMed ID: 24603371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of Antifungal Activity and Nail Penetration of ME1111, a New Antifungal Agent for Topical Treatment of Onychomycosis.
    Tabata Y; Takei-Masuda N; Kubota N; Takahata S; Ohyama M; Kaneda K; Iida M; Maebashi K
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1035-9. PubMed ID: 26643333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fungicidal versus fungistatic activity of terbinafine and itraconazole: an in vitro comparison.
    Hazen KC
    J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S37-41. PubMed ID: 9594935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Trichophyton rubrum onychomycosis with secondary Aspergillus versicolor infection in a 12-year-old girl: successful topical therapy with terbinafine-urea ointment].
    Mayser PA; Gries A; Hamrouni N
    Hautarzt; 2014 Jul; 65(7):628-32. PubMed ID: 24817253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients.
    Ginter-Hanselmayer G; Weger W; Smolle J
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):470-5. PubMed ID: 18194238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosing and treating onychomycosis.
    Zaias N; Glick B; Rebell G
    J Fam Pract; 1996 May; 42(5):513-8. PubMed ID: 8642370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnosis, differential diagnosis and therapy of onychomycosis].
    Seebacher C
    Z Arztl Fortbild Qualitatssich; 1998 Apr; 92(3):187-90. PubMed ID: 9606886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of antifungal agents in onychomycoses.
    Debruyne D; Coquerel A
    Clin Pharmacokinet; 2001; 40(6):441-72. PubMed ID: 11475469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK; Gregurek-Novak T
    Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis.
    Degreef H; del Palacio A; Mygind S; Ginter G; Pinto Soares A; Zuluaga de Cadena A
    Acta Derm Venereol; 1999 May; 79(3):221-3. PubMed ID: 10384922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Onychomycosis.
    Welsh O; Vera-Cabrera L; Welsh E
    Clin Dermatol; 2010 Mar; 28(2):151-9. PubMed ID: 20347657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
    Gupta AK; Lynde CW; Konnikov N
    J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study on the compliance and safety of the oral antifungal agents for the treatment of onychomycosis].
    Hu Y; Yang LJ; Wei L; Dai XY; Hua HK; Qi J; Sun H; Zheng Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Dec; 26(12):988-91. PubMed ID: 16676597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antifungal drug response in an in vitro model of dermatophyte nail infection.
    Osborne CS; Leitner I; Favre B; Ryder NS
    Med Mycol; 2004 Apr; 42(2):159-63. PubMed ID: 15124869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
    Gupta AK
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy.
    Tosti A; Piraccini BM; Stinchi C; Venturo N; Bardazzi F; Colombo MD
    J Am Acad Dermatol; 1996 Apr; 34(4):595-600. PubMed ID: 8601647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.